Intervention Review

You have free access to this content

Corticosteroids for viral myocarditis

  1. Huai Sheng Chen1,*,
  2. Wei Wang2,
  3. Sheng Nan Wu3,
  4. Jian Ping Liu4

Editorial Group: Cochrane Heart Group

Published Online: 18 OCT 2013

Assessed as up-to-date: 25 JUL 2012

DOI: 10.1002/14651858.CD004471.pub3


How to Cite

Chen HS, Wang W, Wu SN, Liu JP. Corticosteroids for viral myocarditis. Cochrane Database of Systematic Reviews 2013, Issue 10. Art. No.: CD004471. DOI: 10.1002/14651858.CD004471.pub3.

Author Information

  1. 1

    The Second Affiliated Hospital of Ji Nan University, Intensive Care Unit, Shenzhen People's Hospital, Shenzhen City, Guangdong, China

  2. 2

    Shenzhen People's Hospital, Endocrinology, Shenzhen City, China

  3. 3

    Shenzhen People's Hospital, The Second Affiliated Hospital of Ji Nan University, Intensive Care Unit, Shenzhen City, GuangDong Province, China

  4. 4

    Beijing University of Chinese Medicine, Centre for Evidence-Based Chinese Medicine, Beijing, China

*Huai Sheng Chen, Intensive Care Unit, Shenzhen People's Hospital, The Second Affiliated Hospital of Ji Nan University, 1017 Dong Men Bei Lu, Luo Hu District, Shenzhen City, Guangdong, 518020, China. sunshinic@hotmail.com.

Publication History

  1. Publication Status: New search for studies and content updated (conclusions changed)
  2. Published Online: 18 OCT 2013

SEARCH

References

References to studies included in this review

  1. References to studies included in this review
  2. References to studies excluded from this review
  3. Additional references
  4. References to other published versions of this review
Aziz 2010 {published data only}
  • Aziz KU, Patel N, Sadullah T, Tasneem H, Thawerani H, Talpur S. Acute viral myocarditis: role of immunosuppression: a prospective randomised study. Cardiology in the Young 2010;20(5):509-15.
Latham 1989 {published data only}
  • Latham RD, Mulrow JP, Virmani R, Robinowitz M, Moody JM. Recently diagnosed idiopathic dilated cardiomyopathy: incidence of myocarditis and efficacy of prednisone therapy. American Heart Journal 1989;117(4):876-882.
Liao 2005 {published data only}
  • Liao RH, Li L, Wang X. Therapeutic effects of comprehensive program plus hormone on viral myocarditis. Acta Academiae Medicinae Militaris Tertiae (Chinese) 2005;27(6):575-6.
Ma 2001 {published data only}
  • Ma PaiRan, Wang ShuJun, Zhuang JianXin, Huang Lei. The treatment effect of corticosteroids on reducing myocardial enzyme in viral myocarditis in children. Shan Dong Medical Journal 2001;41(19):13-14.
Maisch 1995 {published data only}
  • Maisch B, Herzum M, Hufnagel G, Hengstenberg C, Schonian U, Bittinger A, et al. Immunosuppressive treatment in auto-reactive myocarditis results from a placebo-controlled trial. Journal of the American College of Cardiology 1993;21(2 Suppl A):21A.
  • Maisch B, Herzum M, Hufnagel G, Hengstenberg C, Schonian U, Bittinger A, et al. Immunosuppressive treatment in auto-reactive myocarditis: results from a placebo-controlled trial. Journal of the American College of Cardiology 1995;Special Issue:325A.
  • Maisch B, Schonian U, Hengstenberg C, Herzum M, Hufnagel G, Bethge C, et al. Immunosuppressive treatment in autoreactive myocarditis--results from a controlled trial. Postgraduate Medical Journal 1994;70(Suppl 1):S29-34.
Mason 1995 {published data only}
  • Hahn EA, Hartz VL, Moon TE, O'Connell JB, Herskowitz A, Mcmanus BM, et al. The myocarditis treatment trial: design, methods and patient enrolment. European Heart Journal 1995;16(Suppl):162-7.
  • Mason JW, O'Connell JB, Herskowitz A, Rose NR, McManus BM, Billingham ME, et al. A clinical trial of immunosuppressive therapy for myocarditis: The Myocarditis Treatment Trial Investigators. New England Jounral of Medicine 1995;333(5):269-75.
Wojnicz 1999 {published data only}
  • Wojnicz R, Nowalany-Kozielska E, Szczurek-Katanski K, Wodniecki J, Nozynski J, Zembala M, et al. Randomized studies of new therapeutic management in patients with myocarditis. Journal of the American College of Cardiology 1999;2(Suppl A):506A.
  • Wojnicz R, Nowalany-Kozielska E, Wojciechowska C, Glanowska G, Wilczewski P, Niklewski T, et al. Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results. Circulation 2001;104(1):39-45. [PUBMED: 11435335]
Yang 2006 {published data only}
  • Yang CQ, Ding DP. Treatment effects of Shenmai injection combined corticosteroids on acute viral myocarditis in children. Lishizhen Medicine and Materia Medica Research 2006;17(5):872-3.

References to studies excluded from this review

  1. References to studies included in this review
  2. References to studies excluded from this review
  3. Additional references
  4. References to other published versions of this review
Camargo 1995 {published data only}
  • Camargo PR, Snitcowsky R, Da Luz PL, Mazzieri R, Higuchi ML, Rati M, et al. Favorable effects of immunosuppressive therapy in children with dilated cardiomyopathy and active myocarditis. Pediatric Cardiology 1995;16(2):61-8.
Chen 1992 {published data only}
  • Chen SX, Chang BL, Bao SH. Integrated traditional and Western medicine treatment of severe viral myocarditis. Zhongguo Zhong Xi Yi Jie He Za Zhi 1992;12(7):398-401.
ESETCID 2000 {published data only}
  • Hufnagel G, Pankuweit S, Richter A, Schonian U, Maisch B. The European Study of Epidemiology and Treatment of Cardiac Inflammatory Diseases (ESETCID). First epidemiological results. Herz 2000;25(3):279-285.
  • Maisch B, Hufnagel G, Schonian U, Hengstenberg C. The European Study of Epidemiology and Treatment of Cardiac Inflammatory Disease (ESETCID). European Heart Journal 1995;16(Suppl O):173-5.
Frustaci 2009 {published data only}
  • Frustaci A, Russo MA, Chimenti C. Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study. European Heart Journal 2009;30(16):1995-2002.
Kong 2001 {published data only}
  • Kong Qing-fu, Song Shu-zhi, Xie Xue-ying, Zhang Xin-hua, Yue Ge-jie, Chen Zhao-li. Clinical study on therapeutic effects of treatment according to syndrome differentiation of Traditional Chinese Medicine combined with captopril on severe viral myocarditis complicated heart failure. Zhongguo Zhong Xi Yi Jie He Za Zhi 2001;21(7):513-5.
Li 1997 {published data only}
  • Li SenLin, Zhang ZhiGan, Zhou PengYu. Effect of synthetic action of HuangQi, cortisone on acute viral myocarditis. ZhongGuo Zhong Xi Yi Jie He Za Zhi 1997;17(2):118-9.
Ma 2002 {published data only}
  • Ma PaiRan, Wang ShuJun, Yang XiaoHui, Ouyan ShiXiang. The differentia and value of anticardiolipin antibody between pre- and pro- treatment of corticosteroids in children with viral myocarditis. Shandong Medical Journal 2002;42(23):1-3.
Mao 2007 {published data only}
  • Mao KeJiang, Li YiNan. Application research on staged immunological intervention in viral myocarditis patients. Modern Hospital 2007;7(6):31-3.
Sun 1999 {published data only}
  • Sun Dabao. Corticosteroids treatment effects in 36 cases diagnosed with viral myocarditis with ventricle premature beats. Journal of Zhenjiang Medical College 1999;9(2):211.
Wu 1999 {published data only}
  • Wu Yao-zhang, Chen Bing-Wang. Observation on curative effects of astragalus injection combined with glucocorticoid on acutely severe viral myocarditis. Zhongguo Zhong Xi Yi Jie He Ji Jiu Za Zhi 1999;6(8):350-2.
Zhang 2006 {published data only}
  • Zhang ChunTang, Li AnMin, Li Na. Effect of calcium dibutyryladenosine cyclophosph-ate on viral myocarditis. Central Plains Medical Journal 2006;33(8):80-81.
Zhang 2008 {published data only}
  • Zhang JinFu. Effects of 1,6-FDP combined HuangQi injection on 30 children with viral myocardiits. China Eugenic Genetics Medicine 2008;16(6):131-2.

Additional references

  1. References to studies included in this review
  2. References to studies excluded from this review
  3. Additional references
  4. References to other published versions of this review
Adedayo 2011
  • Adedayo O, Iheonunekwu N, Jefferson D. Acute fulminant myocarditis and the 2009 pandemic influenza A virus (H1N1). West Indian Medical Journal 2011;60(2):217-9.
Andreoletti 2009
Angelini 2000
  • Angelini A, Calzolari V, Calabrese F, Boffa GM, Maddalena F, Chioin R, et al. Myocarditis mimicking acute myocardial infarction: role of endomyocardial biopsy in the differential diagnosis. Heart 2000;84(3):245-50.
Barbaro 2011
Batra 2001
Baughman 2006
Cabral 2012
  • Cabral M, Brito MJ, Conde M, Oliveira M, Ferreira G. Fulminant myocarditis associated with pandemic H1N1 influenza A virus. Revista Portuguesa de Cardiologia [Portuguese Journal of Cardiology] 2012;31(7-8):517-20.
Calderaro 2010
  • Calderaro D, Dos Santos Sde S, Tonacio AC, Gualandro DM, Rezende PC, Yu PC, et al. Acute myocarditis in H1N1 influenza A virus infection. Revista Associação da Médica Brasiliera 2010;56(4):394.
Chan 1991
  • Chan KY, Iwahara M, Benson LN, Wilson GJ, Freedom RM. Immunosuppressive therapy in the management of acute myocarditis in children: a clinical trial. Journal of the American College of Cardiology 1991;17(2):458-60.
Chen 2008
  • Chen HS, Wen JM, Wu SN. Clinical management and relevant issues of viral myocarditis. Chinese Journal of Practical Internal Medicine 2008;28(6):510-2.
Cheng 2003
Egger 1997
Fukae 2000
Gagliardi 2004
  • Gagliardi MG, Bevilacqua M, Bassano C, Leonardi B, Boldrini R, Camassei FD. Long term follow up of children with myocarditis treated by immunosuppression and of children with dilated cardiomyopathy. Heart 2004;90(10):1167-71.
Garg 1998
Gdynia 2011
  • Gdynia G, Schnitzler P, Brunner E, Kandolf R, Blaker H, Daum E, et al. Sudden death of an immunocompetent young adult caused by novel (swine origin) influenza A/H1N1-associated myocarditis. Virchows Archiv 2011;458(3):371-6.
Haessler 2011
Hamilton 2009
  • Hamilton TW, Goodman SM, Figgie M. SAS weekly rounds: avascular necrosis. HSS Journal 2009;5(2):99-113.
Heininger 2011
  • Heininger A, Haeberle HA, Fischer I, Beck R, Riessen R, Rohde F, et al. Cytomegalovirus reactivation and associated outcome of critically ill patients with severe sepsis. Critical Care 2011;15(2):R77.
Hia 2004
Higgins 2003
Higgins 2011
  • Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org. Wiley -Blackwell.
Hosenpud 1985
  • Hosenpud JD, McAnulty JH, Niles NR. Lack of objective improvement in ventricular systolic function in patients with myocarditis treated with azathioprine and prednisone. Journal of the American College of Cardiology 1985;6(4):797-801.
ICH-GCP 1997
  • International Conference on Harmonisation Expert Working Group. Code of Federal Regulations & International Conference on Harmonisation Guidelines. Philadelphia: Barnett International/PAREXEL, 1997.
Kalil 2011
Kandolf 2011
Kearney 2001
Kraaij 2011
  • Kraaij MD, Van der Kooij SW, Reinders ME, Koekkoek K, Rabelink TJ, Van Kooten C, et al. Dexamethasone increases ROS production and T cell suppressive capacity by anti-inflammatory macrophages. Molecular Immunology 2011;49(3):549-57.
Liu 1996
  • Liu P, Martimo T, Opavsky MA, Penninger J. Viral myocarditis: balance between viral infection and immune response. Canadian Journal of Cardiology 1996;12(10):935-43.
Liu 2013
  • Liu ZL, Liu ZJ, Liu JP, Kwong JSW. Herbal medicines for viral myocarditis. Cochrane Database of Systematic Reviews 2013, Issue 8. [DOI: 10.1002/14651858.CD003711.pub5]
Ma 1999
  • Ma WZ, Yu JD, Liu ZQ, Wu N, Li LG, Chen HZ, et al. Committee of Myocarditis and Cardiomyopathy: Dealing meeting of Chinese Journal of Cardiovascular Disease. Viewpoints of diagnostic criteria of adult acute viral myocarditis and introduction to the definition and classification of cardiomyopathy of WHO/IHA workshop. Chinese Journal of Cardiovascular Disease 1999;27(6):405-7.
Magula 2003
  • Magula NP, Mayosi BM. Cardiac involvement in HIV-infected people living in Africa: a review. Cardiovascular Journal of South Africa 2003;14(5):231-7. [PUBMED: 14610610]
Mahrholdt 2004
  • Mahrholdt H, Goedecke C, Wagner A, Meinhardt G, Athanasiadis A, Vogelsberg H, et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation 2004;109(10):1250-8.
Mason 2003
McKenna 1996
  • McKenna WJ. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation 1996;93(5):841-2.
McNamara 2002
  • McNamara DM. Diagnosis and medical treatment of inflammatory cardiomyopathy. In: Eric J. Topol editor(s). Textbook of Cardiovascular Medicine. 2nd Edition. Shangdong, China: Lippincott Williams & Wilkins; Shangdong Science & Technology Press, 2002:1899-1913. [: 7-5331-3409-5]
Metzger 2011
Opitz 2011
  • Opitz E, Koch A, Klingel K, Schmidt F, Prokop S, Rahnefeld A, et al. Impairment of immunoproteasome function by β5i/LMP7 subunit deficiency results in severe enterovirus myocarditis. PLoS Pathogens 2011;7(9):e1002233.
Orinius 1968
Pietra 2012
  • Pietra BA, Kantor PF, Bartlett HL, Chin C, Canter CE, Larsen RL, et al. Early predictors of survival to and after heart transplantation in children with dilated cardiomyopathy. Circulation 2012;126(9):1079-86.
Salluh 2010
  • Figueira Salluh JI, Bozza FA, Japiassu AM, Castro Faria Neto HC, Bozza PT, Póvoa P. Corticosteroids in sepsis: pathophysiological rationale and selection of patients. Endocrine, Metabolic & Immune Disorders Drug Targets 2010;10(3):266-73.
Salvi 1989
Schultz 2009
Shauer 2013
  • Shauer A, Gotsman I, Keren A, Zwas DR, Hellman Y, Durst R, et al. Acute viral myocarditis: current concepts in diagnosis and treatment. Israel Medical Association Journal 2013;15(3):180-5.
Simon 2008
  • Simon F, Paule P, Oliver M. Case Report: chikungunya virus-induced myopericarditis: toward an increase of dilated cardiomyopathy in countries with epidemics?. American Journal of Tropical Medicine and Hygiene 2008;78(2):212-3.
Sprung 2011
Tong 2011
  • Tong P, Wu C, Jin H, Mao Q, Yu N, Holz JD, et al. Gene expression profile of steroid-induced necrosis of femoral head of rats. Calcified Tissue International 2011;89(4):271-84.
Uemura 2001
  • Uemura A, Morimoto S, Hiramitsu S, Hishida H. Endomyocardial biopsy findings in 50 patients with idiopathic atrioventricular block: presence of myocarditis. Japanese Heart Journal 2001;42(6):691-700.
Ukimura 2012
  • Ukimura A, Ooi Y, Kanzaki Y, Inomata T, Izumi T. A national survey on myocarditis associated with influenza H1N1pdm2009 in the pandemic and post-pandemic season in Japan. Journal of Infection and Chemotherapy 2012; Vol. 19, issue 3:426-31.
Vester 1997
  • Vester EG, Klein RM, Kuhl U, Schultheiss HP, Perings C, Hennersdorf M. Immunosuppressive therapy for effective suppression of life threatening ventricular tachyarrhythmias in chronic myocarditis. Zeitschrift fur Kardiologie 1997;86(4):298-308.
Yang 2011
  • Yang F, Wu WF, Yan YL, Pang Y, Kong Q, Huang YL. Expression of IL-23/Th17 pathway in a murine model of Coxsackie virus B3-induced viral myocarditis. Virology Journal 2011;8:301.
Zahariadis 2003
Zimmermann 2005
  • Zimmermann O, Kochs M, Zwaka TP, Kaya Z, Lepper PM, Bienek-Ziolkowski M, et al. Myocardial biopsy based classification and treatment in patients with dilated cardiomyopathy. International Journal of Cardiology 2005;104(1):92-100.

References to other published versions of this review

  1. References to studies included in this review
  2. References to studies excluded from this review
  3. Additional references
  4. References to other published versions of this review
Chen 2006